Longevity Investors & VC Firms in North America
216 firms in this list, with a median first check of $450K. 55 of them lead rounds. Generated from verified public data and updated continuously.
Novo Holdings
HellerupSeed–Late Stage$1.1M – $54M
48 people
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
HealthCap
StockholmSeed–Growth
33 people
NLC
AmsterdamPre-Seed–Seed
43 people
Advent Life Sciences
LondonSeed–Series C
28 people
aMoon
Ra'ananaSeed–Late Stage
33 people
Unruly Capital
LondonPre-Seed–Seed
3 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
DOMiNO Ventures
AmsterdamPre-Seed–Seed$216K – $1.1M
31 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Growth
29 people
King River Capital
SydneySeed–Series B
23 people
Apollo Health Ventures
BerlinSeed–Series A
25 people
MVM Life Science Partners
LondonSeed–Growth$20M – $100M
20 people
Exceptional Ventures
LondonPre-Seed–Seed
16 people
Hadean Ventures
OsloSeed–Growth
21 people
Possible Ventures
MunichPre-Seed–Series A$100K – $5M
7 people
Nordstar
LondonGrowth
12 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
16 people
Brookstreet Equity Partners
LondonSeries A–Late Stage
22 people
XGEN Venture
MilanPre-Seed–Series A
21 people
SeedIL Ventures
HerzliyaPre-Seed–Seed$100K – $500K
12 people
Kinled Holding
Hong KongSeed–Series A
1 person
Nano Holdings
TokyoSeed
19 people
Angelini Ventures
RomeSeed–Series A
7 people
Related lists
Investors & VC Firms in North America (12941)Investors & VC Firms in United States (11979)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.





































































































